Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-20.12%
↓ 122% below average
Average (5y)
-9.05%
Historical baseline
Range
High:-1.75%
Low:-20.12%
CAGR
+58.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -20.12% | -37.3% |
| 2023 | -14.65% | -64.1% |
| 2022 | -8.93% | -31.3% |
| 2021 | -6.80% | -289.4% |
| 2020 | -1.75% | +14.5% |
| 2019 | -2.04% | - |